The Clinicopathologic and Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1) Expression in Patients With Prostate Cancer: A Systematic Review and Meta-Analysis

Background: Programmed cell death ligand 1 (PD-L1) expression has been shown to correlate with poor prognosis in diverse human cancers. However, limited data exist on the prognostic and clinicopathologic significance of PD-L1 expression in prostate cancers (PCa), and the curative effect of anti-PD-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan, Huang, Qingying, Zhou, Yaoyao, He, Meizhi, Chen, Jianhong, Gao, Yubo, Wang, Xue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354218/
https://www.ncbi.nlm.nih.gov/pubmed/30733677
http://dx.doi.org/10.3389/fphar.2018.01494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354218/
https://www.ncbi.nlm.nih.gov/pubmed/30733677
http://dx.doi.org/10.3389/fphar.2018.01494

Ejemplares similares